Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mehmet Yılmaz
Observed names:
M. Yilmaz,
Mehmet YILMAZ,
Mehmet Yilmaz
Institution:
Sanko University
Observed institution:
Sanko University
ORCID:
0000-0002-1218-8165
Observed ORCID:
0000-0002-1218-8165
OpenAlex ID:
A5101463249
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
2026
·
Efstathios Kastritis
, Giovanni Palladini
, et al.
·
Blood
·
27
Are infectious diseases and microbiology new fields for thermal therapy research?
2018
·
Deniz Gazel
, Mehmet Yılmaz
·
International Journal of Hyperthermia
·
20
PDF
Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes
2020
·
Zafer Cetin
, Eyup Ilker Saygili
, et al.
·
Frontiers in bioscience
·
12
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients
2024
·
Özgür Mehtap
, Tayfur Toptas
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
7
Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid Leukemia
2022
·
Guray Saydam
, Ali Unal
, et al.
·
International Journal of Hematologic Oncology
·
3
Effect of a novel extracorporeal cytokine apheresis method on endocan, copeptin And interleukin-6 levels in sepsis: An observational prospective study
2020
·
Berna Kaya Uğur
, Hülya Çiçek
, et al.
·
Transfusion and Apheresis Science
·
2
Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable ≥Vgpr Responses Among Immunomodulatory / Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey
2019
·
Meral Beksac
, Guldane Cengiz Seval
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Systemic inflammatory burden at diagnosis predicts survival in Hodgkin lymphoma: a comprehensive evaluation of the Complete Blood Count Score Model
2026
·
Salih Sertaç Durusoy
, Deniz Mıhçıoğlu
, et al.
·
Biomarkers
·
1
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study
2023
·
Mutlu Arat
, Inci Alacacioglu
, et al.
·
Future Oncology
·
1
Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate
2020
·
G. Castaman
, A. Borchiellini
, et al.
·
European Journal of Pharmaceutical Sciences
·
1
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
2019
·
Anil Tombak
, Funda Pepedil Tanrikulu
, et al.
·
Blood
·
1
FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye
2026
·
Zehra Narlı Özdemir
, Fatma Keklik Karadağ
, et al.
·
PLoS ONE
PDF
Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye
2026
·
Aslı Bozdemir
, Sibel Hacıoğlu
, et al.
·
Journal of Clinical Medicine
Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study
2026
·
Ufuk Demirci
, Mehmet Baysal
, et al.
·
Journal of Thrombosis and Thrombolysis
A survey on the management of chronic myeloid leukemia in chronic phase from the perspectives of both patients and physicians
2026
·
Ahmet Emre Eşkazan
, Samet Yaman
, et al.
·
Annals of Hematology
First 1-Year Results of a New Hematopoietic Stem Cell Transplant Center
2024
·
Salih Sertaç Durusoy
, Ömer Aydın Yıldırım
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P1073: a New Scoring System to Predict Survival in Elderly Advanced Stage Hodgkin Lymphoma Patients: Study by Turkish Society of Haematology Lymphoma Academy Working Group
2023
·
Özgür Mehtap
, Tayfur Toptas
, et al.
·
HemaSphere
Relapsed Mantle Cell Lymphoma With Isolated Central Nervous System Involvement That Treated With Ibrutinib; a Case Report and Literature Review
2022
·
Pinar Tiglioglu
, Salih Sertac Durusoy
, et al.
·
Hematology Transfusion and Cell Therapy
PDF
Hematolojik Malignitesi Ve Solid Organ Tümörü Olan Hastalarda RF VE ANTİ-CCP Pozitiflik Oranlarının Saptanması
2022
·
Samet ALKAN
, Bünyamin KISACIK
, et al.
·
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
PDF
Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)
2022
·
Ömür Kayıkçı
, Özgür Mehtap
, et al.
·
Turkish Journal of Hematology
PDF
Essential molecular characterization of AML patients
2020
·
Mehmet Yilmaz
·
Hematology Transfusion and Cell Therapy
PDF
Show more works
View as search
Works count:
21
Citation count:
77
H-index:
4
I10-index:
3
Year
Topic
Type
